Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Camlin Fine Sciences Limited ( (IN:CAMLINFINE) ) has shared an update.
Camlin Fine Sciences Limited announced the outcome of its Securities Issue and Allotment Committee meeting held on November 30, 2025, where it approved the allotment of 41,06,181 fully paid-up equity shares at a price of ₹247.69 per share. This issuance, amounting to over ₹101 crore, is part of a strategic move to acquire shares in the French company Vinpai, enhancing Camlin’s market position and expanding its international footprint. The transaction increases the company’s paid-up equity share capital, reflecting a significant step in its growth strategy.
More about Camlin Fine Sciences Limited
Camlin Fine Sciences Limited operates in the fine chemicals industry, focusing on the production of antioxidants and aroma chemicals. The company is known for its market focus on providing high-quality chemical solutions for food and industrial applications.
Average Trading Volume: 32,193
Technical Sentiment Signal: Buy
Current Market Cap: 31B INR
For detailed information about CAMLINFINE stock, go to TipRanks’ Stock Analysis page.